Judith Anzures‐Cabrera

机构：Roche (United Kingdom)

发表论文 35 篇 · 总被引 2073 次 · h-index 15

代表论文

• Trial of Prasinezumab in Early-Stage Parkinson’s Disease (2022 · New England Journal of Medicine · 被引 419)
• The complement C5 inhibitor crovalimab in paroxysmal nocturnal hemoglobinuria (2020 · Blood · 被引 134)
• The effect of cholesteryl ester transfer protein inhibition on lipids, lipoproteins, and markers of HDL function after an acute coronary syndrome: the dal-ACUTE randomized trial (2014 · European Heart Journal · 被引 89)
• A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data (2021 · Frontiers in Neurology · 被引 88)
• A tool to assess the quality of a meta‐analysis (2013 · Research Synthesis Methods · 被引 84)
• Efficacy and safety of lebrikizumab in adult patients with mild-to-moderate asthma not receiving inhaled corticosteroids (2017 · Respiratory Medicine · 被引 55)